Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation

This study has been terminated.
(Interim analysis indicated study should be terminated)
Information provided by (Responsible Party):
Baxter Healthcare Corporation Identifier:
First received: November 1, 1999
Last updated: May 10, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2003
  Estimated Primary Completion Date: June 2003 (Final data collection date for primary outcome measure)